Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 2/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27655505 | 0.82 | ADAM17 (0.48) | CYP3A4CYP2D6SLC22A1KDM4EOPRM1 | |
| SCHEMBL4813929 | 0.79 | SLC22A1 (0.50) | SLC22A1OPRM1ADRA1AKCNH2OPRD1 | |
| SCHEMBL29204727 | 0.78 | SLC22A1 (0.54) | PRCPSIGMAR1SLC22A1OPRM1ADRA1A | |
| SCHEMBL27634423 | 0.77 | ADAM17 (0.48) | CYP3A4LMNACYP2D6SLC22A1KDM4E | |
| SCHEMBL4808702 | 0.75 | SLC22A1 (0.46) | SLC22A1OPRM1ADRA1AKCNH2OPRD1 | |
| SCHEMBL4813759 | 0.75 | SLC22A1 (0.46) | CYP3A4LMNACYP1A2CYP2D6SLC22A1 | |
| SCHEMBL8320731 | 0.73 | SLC22A1 (0.51) | SLC22A1OPRM1ADRA1AKCNH2OPRD1 | |
| SCHEMBL7164271 | 0.72 | CHRM2 (0.54) | PRCPSIGMAR1ALDH1A1POLBCHRM2 | |
| SCHEMBL4815215 | 0.72 | SLC22A1 (0.43) | LMNASLC22A1TDP1OPRM1OPRD1 | |
| SCHEMBL4810643 | 0.72 | SLC22A1 (0.43) | SLC22A1KDM4EOPRM1ADRA1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4774 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| US-11872307-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2024-01-16 | — | — | US | claimed |
| EP-3682872-B1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-01-03 | — | — | EP | claimed |
| WO-2023205619-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-10-26 | — | — | WO | claimed |
| US-20220211616-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2022-07-07 | — | — | US | claimed |
| EP-1931320-B1 | MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE AND ORAL DOSAGE FORM COMPRISING THE SAME | FLAMEL IRELAND LTD (IE) | 2022-06-15 | — | — | EP | claimed |
| EP-0371085-A1 | DEXTROMETHORPHAN POTENTIATOR FOR ANTICONVULSANT COMPOSITION AND METHOD | PONTECORVO, Michael (US) | 1990-06-06 | — | — | EP | claimed |
| EP-0219458-B1 | MEDICAMENT ADSORBATES AND THEIR PREPARATION | WARNER-LAMBERT COMPANY (US) | 1990-05-23 | — | — | EP | claimed |
| US-4906638-A | Dextromethorphan potentiator for anticonvulsant composition and method | NOVA PHARMACEUTICAL CORPORATION (US) | 1990-03-06 | — | — | US | claimed |
| WO-1989005641-A1 | DEXTROMETHORPHAN POTENTIATOR FOR ANTICONVULSANT COMPOSITION AND METHOD | PONTECORVO MICHAEL J (US) | 1989-06-29 | — | — | WO | claimed |
| EP-0132472-B1 | MEDICATED PRODUCTS CONTAINING A MAGNESIUM TRISILICATE ADSORBENT WITH A MEDICAMENT DRUG ADSORBED THEREON | WARNER-LAMBERT COMPANY (US) | 1989-06-21 | — | — | EP | claimed |
| EP-0233932-A4 | ANTICONVULSANT COMPOSITIONS AND METHOD. | UNIV NEW YORK (US) | 1988-04-26 | — | — | EP | claimed |
| US-4694010-A | DIPHENYLHYDANTOIN AS POTENTIATOR FOR DEXTROMETHORPHAN AS ANTIEPILEPTIC | NEW YORK UNIVERSITY (US) | 1987-09-15 | — | — | US | claimed |
| EP-0233932-A1 | ANTICONVULSANT COMPOSITIONS AND METHOD | NEW YORK UNIVERSITY (US) | 1987-09-02 | — | — | EP | claimed |
| WO-1987001036-A1 | ANTICONVULSANT COMPOSITIONS AND METHOD | NEW YORK UNIVERSITY (US) | 1987-02-26 | — | — | WO | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |